MedPath

High-dose vs. low dose proton pump inhibitor infusion for the prevention of ulcer bleeding after endoscopic submucosal dissectio

Not Applicable
Completed
Conditions
Diseases of the digestive system
Registration Number
KCT0001089
Lead Sponsor
Pusan National University Yangsan Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
300
Inclusion Criteria

From March 2012 to February 2013, patients who gave written informed consent were enrolled. The indications for endoscopic submucosal dissection were early gastric cancer, gastric adenomas or gastric submucosal layer tumors which were confirmed by endoscopic ultrasound.

Exclusion Criteria

The exclusion criteria were: age below 20 or above 80; previous gastroesophageal surgery; or history of allergy to any proton pump inhibitor.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delayed bleeding after endoscopic submucosal dissection
Secondary Outcome Measures
NameTimeMethod
The incidences and risk factors of high risk ulcer stigma
© Copyright 2025. All Rights Reserved by MedPath